Case Report: A case of femoral metastatic cancer misdiagnosed as isolated femoral lesser trochanter avulsion fracture

病例报告:一例股骨转移癌误诊为孤立性股骨小转子撕脱骨折的病例报告

阅读:1

Abstract

OBJECTIVE: To highlight the diagnostic challenges and clinical implications of metastatic disease presenting as an atypical fracture in a patient with a history of lung cancer, emphasizing the importance of maintaining a high index of suspicion for metastatic disease and the need for comprehensive diagnostic approaches. METHODS: We present a case of a 79-year-old male with a history of poorly differentiated squamous cell carcinoma of the left lung who presented with left hip pain after minor trauma. Initial X-ray and CT imaging suggested an avulsion fracture of the femoral lesser trochanter(LT).The patient was managed conservatively with bed rest. However, persistent pain led to further evaluation with MRI, revealing an underlying pathological fracture due to metastatic cancer. RESULTS: Initial radiographic and CT findings showed a localized bone defect and surrounding soft tissue swelling, consistent with an avulsion fracture of the LT. However, MRI and contrast-enhanced MRI revealed irregularities in the femoral LT with abnormal bone marrow signals and a prominent soft tissue mass, leading to the diagnosis of a pathological fracture secondary to metastatic cancer. This case underscores the limitations of initial imaging modalities in detecting subtle bone marrow changes and the importance of MRI in identifying metastatic lesions. CONCLUSION: The misdiagnosis of a pathological fracture as an avulsion fracture can have significant clinical implications, including increased morbidity and delayed treatment of metastatic disease. This case highlights the importance of maintaining a high index of suspicion for metastatic disease, especially in patients with a history of malignancy, and the need for comprehensive diagnostic approaches, including MRI to avoid misdiagnosis. Early recognition and appropriate management of pathological fractures are crucial for improving patient outcomes and quality of life.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。